Planning for HIV preexposure prophylaxis introduction: Lessons learned from contraception

Current Opinion in HIV and AIDS

Volumn 11, Issue 1, 2016, Pages 87-93

  Delany Moretlwe, Sinead ^a   Mullick, Saiqa ^a   Eakle, Robyn ^a   Rees, Helen ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

contraception; family planning; HIV AIDS; preexposure prophylaxis; prevention

Indexed keywords

CONTRACEPTIVE AGENT;

CONTRACEPTION; CONTRACEPTIVE BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRE-EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; REVIEW; SOCIAL ENVIRONMENT; CHEMOPROPHYLAXIS; DISEASE TRANSMISSION; HIV INFECTIONS; ORGANIZATION AND MANAGEMENT; PREVENTION AND CONTROL; PROCEDURES; TRANSMISSION;

CHEMOPREVENTION; DISEASE TRANSMISSION, INFECTIOUS; HIV INFECTIONS; HUMANS; PRE-EXPOSURE PROPHYLAXIS;

EID: 84951909151     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000221     Document Type: Review

References (45)

1. UNAIDS. The Gap Report. 2014.
2. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367:399-410.
3. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363:2587-2599.
4. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012; 367:423-434.
5. Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013; 381:2083-2090.
6. Gomez GB, Borquez A, Case KK, et al. The cost and impact of scaling up preexposure prophylaxis for HIV prevention: a systematic review of costeffectiveness modelling studies. PLoS Med 2013; 10:e1001401.
7. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012; 367:411-422.
8. Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med 2015; 372:509-518.
9. Grant RM, Anderson PL, McMahan V, et al. Uptake of preexposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis 2014; 14:820-829.
10. Mayer KH, Hosek S, Cohen S, et al. Antiretroviral preexposure prophylaxis implementation in the United States: a work in progress. J Int AIDS Soc 2015; 18 (4 Suppl 3):19980.
11. Simmons R, Hall P, Diaz J, et al. The strategic approach to contraceptive introduction. Stud Fam Plann 1997; 28:79-94.
12. WHO. Making Decisions about Contraceptive Introduction: A Guide for Conducting Assessments to Broaden Contraceptive Choice and Improve Quality of Care. Geneva: WHO; 2002.
13. WHO. The WHO Strategic Approach to strengthening sexual and reproductive health policies and programmes. Geneva: WHO; 2007.
14. Darroch JE, Sedgh G, Ball H. Contraceptive technologies: responding to women's needs. New York: Guttmacher Institute; 2011.
15. Crosignani PG, Glasier A. Family planning 2011: better use of existing methods, new strategies and more informed choices for female contraception. Hum Reprod Update 2012; 18:670-681.
16. Sitruk-Ware R, Nath A, Mishell DR Jr. Contraception technology: past, present and future. Contraception 2013; 87:319-330.
17. Ross J, Hardee K. Access to contraceptive methods and prevalence of use. J Biosoc Sci 2013; 45:761-778.
18. Ross J, Keesbury J, Hardee K. Trends in the contraceptive method mix in lowand middle-income countries: analysis using a new 'average deviation' measure. Glob Health Sci Pract 2015; 3:34-55.
19. Mansour D. International survey to assess women's attitudes regarding choice of daily versus nondaily female hormonal contraception. Int J Womens Health 2014; 6:367-375.
20. Ventura SJ, Hamilton BE, Matthews TJ. National and state patterns of teen births in the United States, 1940-2013. Natl Vital Stat Rep 2014; 63:1-34.
21. Krakower DS, Mayer KH. Preexposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges. Drugs 2015; 75:243-251.
22. Nelson AL, Westhoff C, Schnare SM. Real-world patterns of prescription refills for branded hormonal contraceptives: a reflection of contraceptive discontinuation. Obstet Gynecol 2008; 112:782-787.
23. Peipert JF, Zhao Q, Allsworth JE, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011; 117:1105-1113.
24. Beksinska ME, Rees VH, Nkonyane T, McIntyre JA. Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? A study of injectable and oral contraceptive use in Johannesburg. Br J Fam Plann 1998; 24:21-23.
25. Warren M. Condoms: the multipurpose prevention technologies that already exist. BJOG 2014; 121 (Suppl 5):9-11.
26. Harrison PF, Rosenfield A. Research, introduction, and use: advancing from Norplant. Contraception 1998; 58:323-334.
27. Brown GF, Raghavendran V, Walker S. Planning for microbicide access in developing countries: lessons from the introduction of contraceptive technologies. Silver Springs: International Partnership for Microbicides; 2007 ; July 2007.
28. Underhill K, Operario D, Mimiaga MJ, et al. Implementation science of preexposure prophylaxis: preparing for public use. Current HIV/AIDS Rep 2010; 7:210-219.
29. Lindegren ML, Kennedy CE, Bain-Brickley D, et al. Integration of HIV/AIDS services with maternal, neonatal and child health, nutrition, and family planning services. Cochrane Database Syst Rev 2012; 9:CD010119.
30. Succop SM, MacQueen KM, van Loggerenberg F, et al. Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. AIDS Care 2014; 26:1521-1525.
31. Montgomery E, van der Straten A, Stadler J, et al. Male partner influence on women's HIV prevention trial participation and use of preexposure prophylaxis: the importance of 'Understanding'. AIDS Behav 2015; 19:784-793.
32. Maxwell L, Devries K, Zionts D, et al. Estimating the effect of intimate partner violence on women's use of contraception: a systematic review and metaanalysis. PLoS One 2015; 10:e0118234.
33. Allsworth JE, Secura GM, Zhao Q, et al. The impact of emotional, physical, and sexual abuse on contraceptive method selection and discontinuation. Am J Public Health 2013; 103:1857-1864.
34. Delany-Moretlwe S, Cowan FM, Busza J, et al. Providing comprehensive health services for young key populations: needs, barriers and gaps. J Int AIDS Soc 2015; 18 (2 Suppl 1):19833.
35. van der Straten A, Stadler J, Montgomery E, et al. Women's experiences with oral and vaginal preexposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS One 2014; 9:e89118.
36. Liu A, Cohen S, Follansbee S, et al. Early experiences implementing preexposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Medicine 2014; 11:e1001613.
37. Myers JE, Sepkowitz KA. A pill for HIV prevention: deja vu all over again? Clin Infect Dis 2013; 56:1604-1612.
38. Warren M, Philpott A. Expanding safer sex options: introducing the female condom into national programmes. Reprod Health Matters 2003; 11:130-139.
39. Sullivan TM, Bertrand JT, Rice J, Shelton JD. Skewed contraceptive method mix: why it happens, why it matters. J Biosoc Sci 2006; 38:501-521.
40. Chandra-Mouli V, McCarraher DR, Phillips SJ, et al. Contraception for adolescents in low and middle income countries: needs, barriers, and access. Reprod Health 2014; 11:1.
41. Alkema L, Kantorova V, Menozzi C, Biddlecom A. National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis. Lancet 2013; 381:1642-1652.
42. Brady M, Manning J. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel. Antiviral Res 2013; 100 (Suppl):S25-S31. doi: 10. 1016/j. antiviral. 2013. 09. 019. Epub 2013 Nov Review
43. Bass F. A new product growth for model consumer durables. Management Sci 1969; 15:215-227.
44. Beksinska ME, Smit JA, Mantell JE. Progress and challenges to male and female condom use in South Africa. Sex Health 2012; 9:51-58.
45. Peters A, van Driel F, Jansen W. Acceptability of the female condom by sub-Saharan African women: a literature review. Afr J Reprod Health 2014; 18:34-44.